Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a

Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

L04AA01 CICLOSPORINUM CAPS. MOI 100 mg

EQUORAL(R) 100 mg 100 mg IVAX-PHARMACEUTICALS

S.R.O.
L04AA01 CICLOSPORINUM SOL. ORALĂ 100 mg/ml

EQUORAL(R) 100 mg/ml IVAX-PHARMACEUTICALS

S.R.O.

SANDIMMUN NEORAL(R) 100 mg/ml NOVARTIS PHARMA GMBH
L04AA01 CICLOSPORINUM CAPS. MOI 25 mg

CICLORAL(R) HEXAL(R) 25 mg 25 mg HEXAL AG

EQUORAL(R) 25 mg 25 mg IVAX-PHARMACEUTICALS

S.R.O.

SANDIMMUN NEORAL(R) 25 mg NOVARTIS PHARMA GMBH
L04AA01 CICLOSPORINUM CAPS. MOI 50 mg

CICLORAL(R) HEXAL 50 mg 50 mg HEXAL AG

EQUORAL(R) 50 mg 50 mg IVAX-PHARMACEUTICALS

S.R.O.

SANDIMMUN NEORAL(R) 50 mg NOVARTIS PHARMA GMBH

________________________________________________________________________________

______________________________________________________________________________

| 569 |L04AX01| AZATHIOPRINUM* | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

L04AX01 AZATHIOPRINUM COMPR. FILM. 50 mg

IMURAN(R) 50 mg THE WELLCOME FOUNDATION

LTD.

________________________________________________________________________________
SUBLISTA C1 - G29 BOALA GAUCHER.
______________________________________________________________________________

| 570 |A16AB02| IMIGLUCERASUM**** | Protocol: A008E |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

A16AB02 IMIGLUCERASUM PULB. PT. CONC. PT. 200 U

SOL. PERF.

CEREZYME 200 U 200 U GENZYME EUROPE BV

A16AB02 IMIGLUCERASUM PULB. PT. CONC. PT. 400 U

SOL. PERF.

CEREZYME 400 U 400 U GENZYME EUROPE BV

________________________________________________________________________________

______________________________________________________________________________

| 571 |A16AX06| MIGLUSTATUM**** | |

|_______|_______|____________________________________________|_________________|
Prescriere limitată: Tratamentul pe cale orală al bolii Gaucher de tip I, uşoară până la moderată, numai la pacienţii care nu pot fi supuşi terapiei de substituţie enzimatică
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

A16AX06 MIGLUSTATUM CAPS. 100 mg

ZAVESCA 100 mg ACTELION REGISTRATION LTD.

________________________________________________________________________________

SUBLISTA C1 - G30 BOLI VENERICE (SIFILIS, GONOREE, INFECŢIA CU CHLAMIDIA).
______________________________________________________________________________

| 572 |J01AA02| DOXYCYCLINUM |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

J01AA02 DOXYCYCLINUM CAPS. 100 mg

DOXICILINA 100 mg EUROPHARM SA

DOXICILINA 100 mg 100 mg ANTIBIOTICE SA

DOXICICUNA SANDOZ 100 mg 100 mg SANDOZ SRL
J01AA02 DOXYCYCLINUM COMPR. DISP. 100 mg

UNIDOX SOLUTAB 100 mg ASTELLAS PHARMA EUROPE

B.V.
J01AA02 DOXYCYCLINUM CAPS. 100 mg

DOXICILINA 100 mg ARENA GROUP SA

DOXICILINA 100 mg 100 mg ANTIBIOTICE SA

DOXICILINA SANDOZ 100 mg 100 mg SANDOZ SRL

J01AA02 DOXYCYCLINUM COMPR. DISP. 100 mg

UNIDOX SOLUTAB 100 mg ASTELLAS PHARMA EUROPE

B.V.
J01AA02 DOXYCYCLINUM CAPS. 100 mg

DOXICICLINA 100 mg ARENA GROUP SA

DOXICICLINA 100 mg 100 mg ANTIBIOTICE SA

DOXICICLINA SANDOZ 100 mg 100 mg SANDOZ SRL

J01AA02 DOXYCYCLINUM COMPR. DISP. 100 mg

UNIDOX SOLUTAB 100 mg ASTELLAS PHARMA EUROPE

B.V.

________________________________________________________________________________

______________________________________________________________________________

| 573 |J01AA07| TETRACYCLINUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

J01AA07 TETRACYCLINUM CAPS. 250 mg

TETRACICLINA 250 mg 250 mg ANTIBIOTICE SA

TETRACICLINA SANDOZ 250 mg 250 mg SANDOZ SRL

________________________________________________________________________________
______________________________________________________________________________

| 574 |J01CE02| PHENOXYMETHYLPENICILLINUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

J01CE02 COMPR. 1000000 ui

PHENOXYMETHYLPENICILLINUM

PENICILINA V 1 000 000 U.I. 1000000 ui EUROPHARM SA

J01CE02 COMPR. FILM. 1000000 ui

PHENOXYMETHYLPENICILLINUM

OSPEN(R) 1000 1000000 ui SANDOZ GMBH
J01CE02 COMPR. FILM. 1500000 ui

PHENOXYMETHYLPENICILLINUM

OSPEN(R) 1500 1500000 ui SANDOZ GMBH
J01CE02 SIROP 400000 ui/5 ml

PHENOXYMETHYLPENICILLINUM

OSPEN 400 400000 ui/5 ml SANDOZ GMBH
J01CE02 COMPR. FILM. 500000 ui

PHENOXYMETHYLPENICILLINUM

OSPEN(R) 500 500000 ui SANDOZ GMBH

________________________________________________________________________________

______________________________________________________________________________

| 575 |J01CE01| BENZYLPENICILLINUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

J01CE01 BENZYLPENICILLINUM PULB. PT. SOL. INJ. 1000000 ui

PENICILINA G SODICA 1000000 ui ANTIBIOTICE SA
J01CE01 BENZYLPENICILLINUM PULB. PT. SOL. INJ. 1000000 ui

PENICILINA G POTASICA 1000000 ui ANTIBIOTICE SA

J01CE01 BENZYLPENICILLINUM PULB. PT. SOL. INJ. 400000 ui

PENICILINA G SODICA 400000 ui ANTIBIOTICE SA

J01CE01 BENZYLPENICILLINUM PULB. PT. SOL. INJ. 400000 ui

PENICILINA G POTASICA 400000 ui ANTIBIOTICE SA

________________________________________________________________________________
______________________________________________________________________________

| 576 |J01CE08| BENZATHINI BENZYLPENICILLINUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

J01CE08 BENZATHINI PULB. PT. SUSP. INJ. 1200000 ui

BENZYLPENICILLINUM

MOLDAMIN(R) 1200000 ui ANTIBIOTICE SA

J01CE08 BENZATHINI PULB. PT. SUSP. INJ. 600000 ui

BENZYLPENICILLINUM

MOLDAMIN(R) 600000 ui ANTIBIOTICE SA

________________________________________________________________________________

______________________________________________________________________________

| 577 |J01DD08| CEFIXIMUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

J01DD08 CEFIXIMUM GRAN. PT. SUSP. ORALĂ 100 mg/5ml

SUPRAX 100 mg/5 ml GEDEON RICHTER LTD.
J01DD08 CEFIXIMUM CAPS. 200 mg

EFICEF(R) 200 mg 200 mg ANTIBIOTICE SA

J01DD08 CEFIXIMUM COMPR. FILM. 200 mg

SUPRAX 200 mg GEDEON RICHTER LTD.

______________________________________________________________________________

| 578 |J01FA01| ERYTHROMYCINUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

J01FA01 ERYTHROMYCINUM COMPR. 200 mg

ERITROMAGIS 200 mg 200 mg ARENA GROUP SA

ERITROMICINA 200 mg 200 mg ANTIBIOTICE SA

ERITROMICINA EUROPHARM 200 mg 200 mg EUROPHARM SA

ERITROMICINA SANDOZ 200 mg 200 mg SANDOZ S.R.L.

COMPRIMATE

J01FA01 ERYTHROMYCINUM PULB. PT. SUSP. ORALĂ 200 mg/5 ml

ERITRO 200 200 mg/5ml LEK PHARMATECH SRL

________________________________________________________________________________

______________________________________________________________________________

| 579 |J01FA10| AZITHROMYCINUM | |

|_______|_______|____________________________________________|_________________|
Prescriere limitată: Infecţii genitale necomplicate cu Chlamydia trachomatis.